P202 | FRONTLINE NILOTINIB VS DASATINIB IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: A PROPENSITY SCORE ANALYSIS BASED ON AIFA MONITORING REGISTRIES
Frontline second generation tyrosine kinase inhibitors increased the rate of deep molecular responses (DMR) but were also mined by increased related adverse events. A single Asiatic trial randomized the two drugs, dasatinib and nilotinib without differences in efficacy. Aim: the aim of this analysi...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ferrata Storti Foundation
2025-09-01
|
| Colecção: | Haematologica |
| Acesso em linha: | https://haematologica.org/article/view/12399 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|